AVIV BIOMEDICAL, INC.

Medtech · Private

Point-of-care hematofluorometer device that measures bilirubin binding capacity in newborns to prevent neurotoxic hyperbilirubinemia

Grants
$2.0M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
0 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Point-of-Care System for Determination of Bilirubin Capacity in Neonates$983,965
Federal grantDepartment of Health and Human Services · Phase II · Point-of-Care System for Determination of Bilirubin Capacity in Neonates$996,182
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1766NEVA ELECTROMAGNETICS, LLC——
1767Atom Bioworks Inc——
1768LI-COR BIOSCIENCES, INC.——
1769AVIV BIOMEDICAL, INC.——
1770YENOS ANALYTICAL, LLC——
1771River Sonic Solutions LLC——
1772REKOVAR INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 4
  • Bilirubin Hematofluorometer and Reagent Kitapplication
  • Bilirubin Hematolfluorometer And Reagent Kitapplication
  • Bilirubin Hematofluorometer And Reagent Kitapplication
  • Bilirubin Hematofluorometer and Reagent Kitapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.